Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated non‑ionic contrast agent presented as a sterile solution for injection for intra‑arterial and intravenous use. It increases X‑ray attenuation of blood and tissues, providing high‑density iodine atoms that improve visualization of vascular structures during diagnostic imaging procedures.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, diagnostic centres and clinics worldwide with reliable access to EU‑origin contrast media.

Iomeron, an iodinated non‑ionic contrast agent, is used in radiographic imaging to enhance vascular and tissue visualization. - Angiography: Improves delineation of arterial and venous structures during catheter‑based imaging. - Computed tomography (CT) imaging: Provides high‑contrast enhancement of organs and vessels for detailed cross‑sectional images. - Vascular imaging procedures: Facilitates clear visualization of blood flow and vessel anatomy in both intra‑arterial and intravenous studies.

Iomeron may be associated with a range of adverse reactions following intravascular administration.

Common Side Effects: - Warmth or flushing sensation at the injection site. - Metallic taste in the mouth. - Nausea or mild vomiting. - Headache. - Transient urticaria or mild skin rash. - Mild hypotension.

Serious or Rare Side Effects: - Severe allergic reaction or anaphylaxis. - Acute renal impairment, especially in patients with pre‑existing kidney disease. - Persistent hypotension or cardiovascular collapse. - Cardiac arrhythmias. - Seizures. - Pulmonary edema.

Prior to administration, clinicians should evaluate patient risk factors and follow appropriate safety measures. - Renal function assessment: Verify baseline creatinine or eGFR to minimize contrast‑induced nephropathy. - Allergy screening: Identify any known iodine or contrast media hypersensitivity. - Thyroid monitoring: Use caution in patients with hyperthyroidism or thyroid disorders. - Hydration: Ensure adequate patient hydration before and after the procedure. - Store at ambient temperature: Keep in original container, protect from moisture and direct light.

Iomeron can interact with other medications or agents that affect renal function or iodine handling.

Major Interactions (Avoid): - Concurrent administration of other iodinated contrast media: Increases risk of iodine overload. - Nephrotoxic drugs (e.g., aminoglycosides, amphotericin B, high‑dose NSAIDs): May exacerbate renal dysfunction. - Radioactive iodine therapy: May interfere with iodine uptake and therapeutic efficacy.

Moderate Interactions (Monitor Closely): - Diuretics: May alter fluid balance and affect contrast distribution. - ACE inhibitors or ARBs: May increase risk of contrast‑induced nephropathy; consider temporary discontinuation. - Anticoagulants: May raise the risk of bleeding at the injection site.